Phase 1/2 trial of ixazomib, cyclophosphamide, and dexamethasone for newly diagnosed multiple myeloma (NDMM).
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Martha Lacy, P. Leif Bergsagel, Betsy LaPlant, Alese Halvorson, Francis Buadi, Nelson Leung, Ronald S. Go, David Dingli, Prashant Kapoor, Morie A. Gertz, Yi Lin, Angela Dispenzieri, Yi Lisa Hwa, Amie Fonder, Rafael Fonseca, Suzanne R. Hayman, A. Keith Stewart, Joseph Mikhael, S. Vincent Rajkumar, Shaji Kumar
Institutions: Mayo Clinic, Mayo Clinic in Arizona
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2762968554